Genentech Says Avastin Trial Did Not Meet Goal PharmaLive (press release) (subscription) Avastin is approved to treat advanced colorectal, breast, lung and kidney cancer. Genentech said full results from the study will be presented in June at a ...
Pfizer breast cancer drug fails in two studies IBTimes Pfizer's breast cancer drug Sutent (sunitinib malate) failed to meet its primary endpoints in two phase three trials, the firm said today (12 March). ...
Pfizer Disappointed in Study Results for Two Drugs Wall Street Journal The drug giant also announced two Phase III studies of its advanced breast-cancer drug Sutent failed to meet their primary endpoints. ...
Genentech says Avastin trial did not meet goal BusinessWeek Avastin is approved to treat advanced colorectal, breast, lung and kidney cancer. Genentech said full results from the study will be presented in June at a ...
Pfizer reports more setbacks in drug tests TheDay.com Pfizer also said two late-stage studies of Sutent, known generically as sunitinib malate, did not help patients with advanced breast cancer. ...
Genentech Says Avastin Trial Did Not Meet Goal PharmaLive.com (press release) Avastin is approved to treat advanced colorectal, breast, lung and kidney cancer. Genentech said full results from the study will be presented in June at a ...
Pfizer Says Sutent Fails In Breast Cancer Studies PharmaLive (press release) (subscription) Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Coping with Stress: Making Plans in Uncertain Times EmpowHer (blog) My wife, Chris, had been through breast cancer and then, 18 months later, the cancer reappeared throughout her skeleton. After more chemo and radiation the ...
AnnTaylor, National Semiconductor, Aeropostale MarketWatch Pfizer Inc. (NYSE:PFE) said two of its late-stage studies of an approved kidney cancer drug failed to treat breast cancer significantly, and that it will ...
